A detailed history of Trace Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trace Wealth Advisors, LLC holds 7,342 shares of BMY stock, worth $403,663. This represents 0.37% of its overall portfolio holdings.

Number of Shares
7,342
Holding current value
$403,663
% of portfolio
0.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$51.92 - $59.94 $381,196 - $440,079
7,342 New
7,342 $415 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $117B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Trace Wealth Advisors, LLC Portfolio

Follow Trace Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trace Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trace Wealth Advisors, LLC with notifications on news.